Intrahepatic Delivery of SD-101 by Pressure-Enabled Regional Immuno-oncology (PERIO), With Checkpoint Blockade in Adults With Metastatic Uveal Melanoma
Clinical trial NCT04935229 · TERMINATED
Trial details
- NCT number
- NCT04935229
- Sponsor
- TriSalus Life Sciences, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-02
- Primary completion
- 2024-07-17
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.